Every SEC Form 3/4/5 on record for this filer (CIK 1829252) — 2 issuers, 211 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | EVP Chief R&D | 2022-01-04 → 2026-03-06 | 26 | −$36M |
| SQZ | SQZ Biotechnologies Co | Director · lapsed | 2020-10-29 → 2023-06-15 | 5 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| ALNY | 2026-03-05 | Sell | 654 | $322.33 | $210,804 | 20,443 |
| ALNY | 2026-03-05 | Sell | 740 | $323.55 | $239,427 | 19,703 |
| ALNY | 2026-03-05 | Sell | 510 | $324.59 | $165,541 | 19,193 |
| ALNY | 2026-03-05 | Sell | 500 | $326.08 | $163,040 | 18,693 |
| ALNY | 2026-03-04 | Sell | 215 | $320.81 | $68,974 | 22,983 |
| ALNY | 2026-03-04 | Sell | 289 | $321.82 | $93,006 | 22,694 |
| ALNY | 2026-03-04 | Sell | 350 | $323.01 | $113,054 | 22,344 |
| ALNY | 2026-03-04 | Sell | 767 | $323.84 | $248,385 | 21,577 |
| ALNY | 2026-03-04 | Sell | 272 | $324.88 | $88,367 | 21,305 |
| ALNY | 2026-03-04 | Sell | 208 | $325.67 | $67,739 | 21,097 |
1 of 2 issuers are covered and open a security page; the rest are on file here only.